220 related articles for article (PubMed ID: 27183609)
21. Gastroschisis: incidence, complications, and clinical management in the neonatal intensive care unit.
Lund CH; Bauer K; Berrios M
J Perinat Neonatal Nurs; 2007; 21(1):63-8. PubMed ID: 17301669
[TBL] [Abstract][Full Text] [Related]
22. The effect on the intestines of continuous release of methylene blue from a drug delivery system: an experimental study in a chick embryo gastroschisis model.
Denli O; Barlas M; Bingol-Kologlu M; Yagmurlu A; Ozdamar S; Hasçiçek C; Cedden F
Pediatr Surg Int; 2004 Aug; 20(8):609-13. PubMed ID: 15338173
[TBL] [Abstract][Full Text] [Related]
23. Urinary trypsin inhibitor present in fetal urine prevents intraamniotic meconium-induced intestinal damage in gastroschisis.
Olguner M; Hakgüder G; Ateş O; Cağlar M; Ozer E; Akgür FM
J Pediatr Surg; 2006 Aug; 41(8):1407-12. PubMed ID: 16863846
[TBL] [Abstract][Full Text] [Related]
24. Prenatal extra-abdominal bowel dilatation is a risk factor for intrapartum fetal compromise for fetuses with gastroschisis.
Brown N; Nardi M; Greer RM; Petersen S; Thomas J; Gardener G; Cincotta R; Kumar S
Prenat Diagn; 2015 Jun; 35(6):529-33. PubMed ID: 25394717
[TBL] [Abstract][Full Text] [Related]
25. Heme oxygenase-1 deficiency results in splenic T-cell dysregulation in offspring of mothers exposed to late gestational inflammation.
Ozen M; Zhao H; Kalish F; Yang Y; Folkins A; Burd I; Wong RJ; Stevenson DK
Am J Reprod Immunol; 2018 May; 79(5):e12829. PubMed ID: 29484761
[TBL] [Abstract][Full Text] [Related]
26. Transamniotic stem cell therapy: a novel strategy for the prenatal management of congenital anomalies.
Fauza DO
Pediatr Res; 2018 Jan; 83(1-2):241-248. PubMed ID: 28915235
[TBL] [Abstract][Full Text] [Related]
27. Co-ordinate expression of Th1/Th2 phenotypes in maternal and fetal blood: evidence for a transplacental nexus.
Tse DB; Young BK
J Perinat Med; 2012 Jan; 40(2):165-70. PubMed ID: 22718606
[TBL] [Abstract][Full Text] [Related]
28. Transamniotic stem cell therapy (TRASCET) in a leporine model of gastroschisis.
Feng C; Graham CD; Shieh HF; Brazzo JA; Connors JP; Rohrer L; Papadakis A; Zurakowski D; Fauza DO
J Pediatr Surg; 2017 Jan; 52(1):30-34. PubMed ID: 27836365
[TBL] [Abstract][Full Text] [Related]
29. Evidence for immunological priming and increased frequency of CD4+ CD25+ cord blood T cells in children born to mothers with type 1 diabetes.
Holm BC; Svensson J; Akesson C; Arvastsson J; Ljungberg J; Lynch K; Ivarsson SA; Lernmark A; Cilio CM;
Clin Exp Immunol; 2006 Dec; 146(3):493-502. PubMed ID: 17100770
[TBL] [Abstract][Full Text] [Related]
30. IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6).
Huffnagle GB; Boyd MB; Street NE; Lipscomb MF
J Immunol; 1998 Mar; 160(5):2393-400. PubMed ID: 9498782
[TBL] [Abstract][Full Text] [Related]
31. Pretreatment of gastroschisis with transabdominal amniotic fluid exchange.
Aktuğ T; Demir N; Akgür FM; Olguner M
Obstet Gynecol; 1998 May; 91(5 Pt 2):821-3. PubMed ID: 9572175
[TBL] [Abstract][Full Text] [Related]
32. Eosinophil recruitment into sites of delayed-type hypersensitivity reactions in mice.
Teixeira MM; Talvani A; Tafuri WL; Lukacs NW; Hellewell PG
J Leukoc Biol; 2001 Mar; 69(3):353-60. PubMed ID: 11261781
[TBL] [Abstract][Full Text] [Related]
33. Prolonged eosinophil production after allergen exposure in IFN-gammaR KO mice is IL-5 dependent.
Zhao LL; Lötvall J; Lindén A; Tomaki M; Sjöstrand M; Bossios A
Scand J Immunol; 2008 May; 67(5):480-8. PubMed ID: 18405326
[TBL] [Abstract][Full Text] [Related]
34. [Role of the amniotic fluid in gastroschisis. An experimental study].
Albert A; Juliá V; Morales L; Rovira J; Sancho A; Bombi JA
Cir Pediatr; 1992 Jan; 5(1):12-6. PubMed ID: 1533134
[TBL] [Abstract][Full Text] [Related]
35. Human mid-gestation amniotic fluid contains interleukin-16 bioactivity.
Thornton CA; Holloway JA; Shute JK; Holloway JW; Diaper ND; Warner JO
Immunology; 2009 Apr; 126(4):543-51. PubMed ID: 19278422
[TBL] [Abstract][Full Text] [Related]
36. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
[TBL] [Abstract][Full Text] [Related]
37. Corticosteroid effect upon intestinal and hepatic interleukin profile in a gastroschisis rat model.
Gonçalves FL; Bittencourt DG; Velloso LA; Schmidt AF; Gallindo RM; Sbragia L
Acta Cir Bras; 2013; 28 Suppl 1():8-12. PubMed ID: 23381817
[TBL] [Abstract][Full Text] [Related]
38. Proinflammatory macrophage migratory inhibition factor and interleukin-6 are concentrated in pleural effusion of human fetuses with prenatal chylothorax.
Chen M; Hsieh CY; Shih JC; Chou CH; Ma GC; Chen TH; Lee TH; Tsai HD; Cameron AD; Chen CP
Prenat Diagn; 2007 May; 27(5):435-41. PubMed ID: 17295350
[TBL] [Abstract][Full Text] [Related]
39. Multiple cytokine analysis in gastroschisis: Association with adverse outcomes including fetal brain damage.
Owaki T; Imai K; Miki R; Niwa Y; Kotani T; Nakano-Kobayashi T; Ushida T; Kajiyama H
Cytokine; 2021 Feb; 138():155406. PubMed ID: 33341000
[TBL] [Abstract][Full Text] [Related]
40. Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model.
Callejas GH; Figueira RL; Gonçalves FLL; Volpe FAP; Zuardi AW; Crippa JA; Hallak JE; Sbragia L
Braz J Med Biol Res; 2018 Mar; 51(5):e7132. PubMed ID: 29561958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
